Delivery Order SPE2DR25D3201-SPE2DR26FT4LU
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,649.76 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The contract involves no set-aside designation, and performance will occur at the vendor's corporate office location...
- The Defense Logistics Agency awarded a $13,997.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 5, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,342.54 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, this firm fixed-price delivery order represents a non-competitive, non-set-aside purchase under AmerisourceBergen's existing contract vehicle with the agency. The order will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on August 5, 2025, represents a single transaction under a larger contract vehicle. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $10,092.48 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, this firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $28,879.57 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. Issued on November 17, 2025, with an ultimate completion date of November 18, 2025, this firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contract is being fulfilled from the company's place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,156.22 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award was made on November 24, 2025, with an ultimate completion date of November 25, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...